Open Access
Issue
OCL
Volume 18, Number 1, Janvier-Février 2011
Dossier : Lipides et inflammation
Page(s) 31 - 33
Section Nutrition – Santé
DOI https://doi.org/10.1051/ocl.2011.0365
Published online 15 January 2011
  • Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006 ; 83 : 1505S–1519S. [PubMed] [Google Scholar]
  • Corwin RL. Effects of dietary fats on bone health in advanced age. Prostaglandins, leukotrienes, and essential fatty acids 2003 ; 68 : 379–386. [CrossRef] [PubMed] [Google Scholar]
  • Laneuville O, Breuer DK, Xu N, et al. Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)-octadecatrienoic acids from alpha-linolenic acid. The J Biol Chem 1995 ; 270 : 19330–19336. [CrossRef] [PubMed] [Google Scholar]
  • Mann V, Huber C, Kogianni G, Collins F, Noble B. The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro. Bone 2007 ; 40 : 674–684. [CrossRef] [PubMed] [Google Scholar]
  • Ono K, Kaneko H, Choudhary S, et al. Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 2005 ; 20 : 23–29. [CrossRef] [PubMed] [Google Scholar]
  • Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 2007 ; 295 : 45–52. [CrossRef] [PubMed] [Google Scholar]
  • Poulsen RC, Wolber FM, Moughan PJ, Kruger MC. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. Prostaglandins & Other Lipid Mediators 2008 ; 85 : 42–48. [CrossRef] [PubMed] [Google Scholar]
  • Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol 2008 ; 214 : 201–209. [CrossRef] [PubMed] [Google Scholar]
  • Raisz LG, Alander CB, Simmons HA. Effects of prostaglandin E3 and eicosapentaenoic acid on rat bone in organ culture. Prostaglandins 1989 ; 37 : 615–625. [CrossRef] [PubMed] [Google Scholar]
  • Shen CL, Yeh JK, Rasty J, Li Y, Watkins BA. Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr 2006 ; 95 : 462–468. [CrossRef] [PubMed] [Google Scholar]
  • Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine & Growth Factor Reviews 2004 ; 15 : 457–475. [CrossRef] [PubMed] [Google Scholar]
  • Tsutsumi R, Xie C, Wei X, et al.. PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysis. J Bone Miner Res 2009 ; 24 : 1753–1762. [CrossRef] [PubMed] [Google Scholar]
  • Valverde P. Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio. Curr Med Chem 2008 ; 15 : 284–304. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.